Sugi Predict

Sugi Predict / Compounds / SCHEMBL1174553

SCHEMBL1174553

SCHEMBL1174553

Cc1c(C(=O)NO)sc2c1CN(C(=O)c1ccc(C(C)(C)C)cc1)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.47
▸ WDR77 Q9BQA1 2/20 0.47
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HDAC1 Q13547 2/20 0.44
▸ HPGD P15428 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ TRPV1 Q8NER1 1/20 0.42
▸ HDAC6 Q9UBN7 5/20 0.42
▸ GRIN2C Q14957 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MITF O75030 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KLF5 Q13887 1/20 0.40
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ FLT3 P36888 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1175401 0.87 PRMT5 (0.48) PRMT5WDR77KMT2AALDH1A1HTT
SCHEMBL1174262 0.86 HDAC6 (0.52) PRMT5WDR77MEN1KMT2AALDH1A1
SCHEMBL1174139 0.85 HDAC6 (0.51) PRMT5WDR77MEN1KMT2AHDAC1
SCHEMBL1174052 0.79 HDAC6 (0.57) PRMT5WDR77HDAC1HDAC6MAPT
SCHEMBL1175153 0.77 HDAC6 (0.67) PRMT5WDR77MEN1KMT2AALDH1A1
SCHEMBL1173854 0.77 HDAC6 (0.64) PRMT5WDR77MEN1KMT2ASMN1; SMN2
SCHEMBL1174092 0.76 L3MBTL1 (0.46) PRMT5WDR77KMT2AALDH1A1SMN1; SMN2
SCHEMBL7797678 0.74 GRM5 (0.49) PRMT5WDR77ALDH1A1HDAC6
SCHEMBL7796318 0.74 HDAC6 (0.56) PRMT5WDR77HDAC1HDAC6HDAC8
SCHEMBL1174116 0.73 HDAC1 (0.54) PRMT5WDR77MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8624040-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-01-07 — — US claimed
US-20140329836-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-11-06 — — US disclosed
US-20140329836-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-11-06 — — US disclosed
US-8624040-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-01-07 — — US disclosed
US-20110046157-A1 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-02-24 — — US disclosed
US-20110046157-A1 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-02-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329836-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC5, HDAC1 PRMT5 821/4885WDR77 1675/4885MEN1 3742/4885
US-20110046157-A1 Substituted hydroxamic acids and uses thereof HDAC6, HDAC5, HDAC1 PRMT5 821/4885WDR77 1675/4885MEN1 3742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.